Floatz logo

Arcoxia,

Regional Anesthesia

Umeå UniversityN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Regional Anesthesia cohort.

Asset / SponsorPhaseRating
LIDOCAINE
The University of Texas Health Science Center, Houston
Phase 4BB
ROPIVACAINE
Democritus University of Thrace
Phase 4BB
DEXAMETHASONE
University of Cincinnati
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
The University of Texas Health Science Center, Houston
Phase 4BB
Zofran
Umeå University
N/AD

View all 15 →

Same molecule, other indications

Arcoxia, is also rated in:

breast neoplasmDormant
D
Indicative ·
30 / 100
View asset →
AnesthesiaDormant
D
Indicative ·
30 / 100
View asset →
iatrogenic diseaseDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →